Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Utah Medical Products (UTMD) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Utah Medical Products (UTMD) over the last 16 years, with Q3 2025 value amounting to $4.2 million.

  • Utah Medical Products' Cost of Revenue rose 11.9% to $4.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.6 million, marking a year-over-year decrease of 873.4%. This contributed to the annual value of $16.8 million for FY2024, which is 1697.22% down from last year.
  • Utah Medical Products' Cost of Revenue amounted to $4.2 million in Q3 2025, which was up 11.9% from $4.4 million recorded in Q2 2025.
  • Utah Medical Products' Cost of Revenue's 5-year high stood at $5.3 million during Q2 2022, with a 5-year trough of $3.8 million in Q4 2024.
  • Over the past 5 years, Utah Medical Products' median Cost of Revenue value was $4.7 million (recorded in 2023), while the average stood at $4.6 million.
  • Its Cost of Revenue has fluctuated over the past 5 years, first surged by 2559.29% in 2021, then plummeted by 2674.31% in 2024.
  • Utah Medical Products' Cost of Revenue (Quarter) stood at $4.8 million in 2021, then increased by 9.29% to $5.2 million in 2022, then decreased by 0.23% to $5.2 million in 2023, then fell by 26.74% to $3.8 million in 2024, then rose by 9.73% to $4.2 million in 2025.
  • Its last three reported values are $4.2 million in Q3 2025, $4.4 million for Q2 2025, and $4.2 million during Q1 2025.